Home › Funds › CAPITAL COUNSEL LLC/NY › TECH
CAPITAL COUNSEL LLC/NY position in TECH
BIO-TECHNE CORP · Health Care
CAPITAL COUNSEL LLC/NY reported holding 73,850 shares of TECH (BIO-TECHNE CORP) in its Q2 2026 13F filing — a position valued at US$5.2M, representing 0.22% of its reported portfolio and ranking #20 among its reported holdings. CAPITAL COUNSEL LLC/NY has disclosed TECH holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How CAPITAL COUNSEL LLC/NY's TECH position evolved
CAPITAL COUNSEL LLC/NY first disclosed a stake in TECH in Q3 2025 at 74,000 shares (US$4.1M). The position peaked in Q2 2026 at 73,850 shares, worth US$5.2M. Across 4 filings, CAPITAL COUNSEL LLC/NY held the position steady without any share-count change. The most recent filing (Q2 2026) shows 73,850 shares valued at US$5.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 74.00K | $4.12M | New |
| Q4 2025 | 73.85K | $4.34M | Hold |
| Q1 2026 | 73.85K | $3.86M | Hold |
| Q2 2026 | 73.85K | $5.22M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECH and 13F data
TECH (BIO-TECHNE CORP) is a Health Care company. 29 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECH
- HBK INVESTMENTS L P 6.83M sh · $482.19M · Q2 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.35M sh · $236.60M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 3.16M sh · $223.52M · Q2 2026
- MAIRS & POWER INC 2.70M sh · $190.80M · Q2 2026
- WHITEBOX ADVISORS LLC 2.10M sh · $148.37M · Q2 2026
- RGM Capital, LLC 2.15M sh · $126.56M · Q4 2025
More on CAPITAL COUNSEL LLC/NY
FAQ
How long has CAPITAL COUNSEL LLC/NY held TECH?
CAPITAL COUNSEL LLC/NY has disclosed TECH holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is CAPITAL COUNSEL LLC/NY's current position in TECH?
As of Q2 2026, CAPITAL COUNSEL LLC/NY holds 73.85K shares of TECH (BIO-TECHNE CORP), valued at $5.22M, representing 0.22% of its reported portfolio and ranking #20.
Has CAPITAL COUNSEL LLC/NY been buying or selling TECH?
In the latest 13F filing (Q2 2026), CAPITAL COUNSEL LLC/NY held unchanged its position in TECH. The position peaked in Q2 2026 at 73.85K shares.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.